Publications by authors named "Margrethe J Jensen"
In patients with out-of-hospital cardiac arrest (OHCA), the initial prehospital treatment and transfer of patients directly to intervention clinics-bypassing smaller hospitals-have improved outcomes in recent years. Despite the improved treatment strategies, some patients develop myoclonic status following OHCA, and this phenomenon is usually considered an indicator of poor outcome. With this study, we wanted to challenge this perception.
View Article and Find Full Text PDFArticle Synopsis
- This study examines the impact of discontinuing the antiplatelet drug ticagrelor before cardiac surgery to reduce the risk of major bleeding complications.
- It involved analyzing data from 3,377 patients, comparing those who took ticagrelor with those who only took aspirin prior to surgery.
- Findings indicated that stopping ticagrelor 0-72 hours before surgery significantly increased the risk of major bleeding, while discontinuation 72-120 hours before was not linked to a higher risk.